the leukocyte adherence inhibition ( lai ) assay was utilized as a test for cellular immunity to epstein-barr virus ( ebv ) antigens in 22 patients with infectious mononucleosis ( im ) , 47 patients with lymphoma , 101 carcinoma patients , and 84 subjects without cancer .
C0024299
lymphoma
C0006826
cancer